Episurf Medical to present at Redeye Medtech & Diagnostics seminar on May 5, 2020

Episurf Medical (Nasdaq: EPIS B) will attend Digital Investor Forum on May 5 2020. The event is arranged by Redeye and the company will be represented by the CEO Pål Ryfors.

The presentation will be available live at 11:35 on https://www.redeye.se/events#/event/779848. The presentation will also be available after the conference at Redeye’s website, as well as on the company’s website.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: